# Study to Investigate the Absolute Bioavailability of a Single Oral Dose of Ponesimod in Healthy Male Subjects

> **NCT02068235** · PHASE1 · COMPLETED · sponsor: **Actelion** · enrollment: 17 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ponesimod 5mg i.v.
- **DRUG:** Ponesimod i.v.
- **DRUG:** Ponesimod 10 mg tablet

## Key facts

- **NCT ID:** NCT02068235
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2015-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02068235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02068235, "Study to Investigate the Absolute Bioavailability of a Single Oral Dose of Ponesimod in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02068235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*